Follistatin-like protein 1 and its role in inflammation and inflammatory diseases

Immunologic Research

Volumn 59, Issue 1-3, 2014, Pages 266-272

  Chaly, Yury ^a   Hostager, Bruce ^a   Smith, Sonja ^a   Hirsch, Raphael ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cytokines; Follistatin like protein 1; Inflammasome; Macrophages; Monocytes

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; FOLLISTATIN LIKE PROTEIN 1; FOLLISTATIN RELATED PROTEIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; FSTL1 PROTEIN, HUMAN; FSTL1 PROTEIN, MOUSE;

ARTHRITIS; CELL LINEAGE; CINCA SYNDROME; DERMATOMYOSITIS; EMBRYO DEVELOPMENT; GENE STRUCTURE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; MACROPHAGE ACTIVATION SYNDROME; MESENCHYMAL STROMA CELL; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; OBESITY; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ULCERATIVE COLITIS; ANIMAL; ART; ARTHRITIS, EXPERIMENTAL; GENETICS; IMMUNOLOGY; MOUSE; MUTANT MOUSE STRAIN; PATHOLOGY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BIOLOGICAL MARKERS; CHEMOKINES; FOLLISTATIN-RELATED PROTEINS; HUMANS; INFLAMMATION; MICE; MICE, MUTANT STRAINS; PORTRAITS AS TOPIC;

EID: 84905732462     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-014-8526-z     Document Type: Review

References (51)

1. Shibanuma M, Mashimo J, Mita A, Kuroki T, Nose K. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur J Biochem/FEBS. 1993;217(1):13-9.
2. Geng Y, Dong Y, Yu M, Zhang L, Yan X, Sun J, et al. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proc Natl Acad Sci USA. 2011;108(17):7058- 63. doi:10.1073/pnas.1007293108.
3. Sylva M, Li VS, Buffing AA, van Es JH, van den Born M, van der Velden S, et al. The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis. PLoS One. 2011;6(8):e22616. doi:10.1371/journal.pone.0022616.
4. Tanaka M, Ozaki S, Osakada F, Mori K, Okubo M, Nakao K. Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases. Int Immunol. 1998;10(9):1305-14. (Pubitemid 28414336)
5. Wilson DC, Marinov AD, Blair HC, Bushnell DS, Thompson SD, Chaly Y, et al. Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2010;62(8):2510-6. doi:10.1002/art.27485.
6. Chaly Y, Marinov AD, Oxburgh L, Bushnell DS, Hirsch R. FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expression. Arthritis Rheum. 2012;64(4):1082-8. doi:10.1002/art.33422.
7. Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012;10(6):709-16. doi:10.1016/j.stem.2012.05.015.
8. Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 2012;20(1):14-20. doi:10.1038/mt.2011.211.
9. Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13(4):392-402. doi:10.1016/j.stem.2013.09. 006.
10. Oshima Y, Ouchi N, Sato K, Izumiya Y, Pimentel DR, Walsh K. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation. 2008;117(24):3099-108. doi:10.1161/CIRCULATIONAHA. 108.767673.
11. Liu S, Shen H, Xu M, Liu O, Zhao L, Liu S, et al. FRP inhibits ox-LDL-induced endothelial cell apoptosis through an Akt-NF-{kappa}B-Bcl-2 pathway and inhibits endothelial cell apoptosis in an apoE-knockout mouse model. Am J Physiol Endocrinol Metab. 2010;299(3):E351-63. doi:10.1152/ajpendo.00005. 2010.
12. Ouchi N, Oshima Y, Ohashi K, Higuchi A, Ikegami C, Izumiya Y, et al. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J Biol Chem. 2008;283(47):32802-11. doi:10.1074/jbc.M803440200.
13. Trojan L, Schaaf A, Steidler A, Haak M, Thalmann G, Knoll T, et al. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res. 2005;25(1A):183-91. (Pubitemid 40470109)
14. Sundaram GM, Common JE, Gopal FE, Srikanta S, Lakshman K, Lunny DP, et al. 'See-saw' expression of microRNA-198 and FSTL1 from a single transcript in wound healing. Nature. 2013;495(7439):103-6. doi:10.1038/nature11890.
15. Chaly Y, Blair HC, Smith SM, Bushnell DS, Marinov AD, Campfield BT, et al. Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cells. Ann Rheum Dis. 2014;. doi:10.1136/annrheumdis-2013-204822.
16. Hambrock HO, Kaufmann B, Muller S, Hanisch FG, Nose K, Paulsson M, et al. Structural characterization of TSC-36/Flik: analysis of two charge isoforms. J Biol Chem. 2004;279(12):11727-35. doi:10.1074/jbc.M309318200. (Pubitemid 38401677)
17. Zwijsen A, Blockx H, Van Arnhem W, Willems J, Fransen L, Devos K, et al. Characterization of a rat C6 glioma-secreted follistatin-related protein (FRP). Cloning and sequence of the human homologue. Eur J Biochem. 1994;225(3):937-46.
18. Murakami K, Tanaka M, Usui T, Kawabata D, Shiomi A, Iguchi-Hashimoto M, et al. Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4. FEBS Lett. 2012;586(4):319-24. doi:10.1016/j.febslet.2012.01.010.
19. Li L, Li X, Liu X, Dong Y, Geng Y, Liu X, et al. Expression, characterization, and preliminary X-ray crystallographic analysis of recombinant murine follistatin-like 1 expressed in Drosophila S2 cells. Biosci Trends. 2013;7(2):93-100.
20. Phillips DJ, de Kretser DM. Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol. 1998;19(4):287-322. doi:10.1006/frne.1998.0169. (Pubitemid 28487798)
21. Phillips DJ, Jones KL, Clarke IJ, Scheerlinck JP, de Kretser DM. Activin A: from sometime reproductive factor to genuine cytokine. Vet Immunol Immunopathol. 2005;108(1-2):23-7. doi:10.1016/j.vetimm.2005.08.011. (Pubitemid 41317062)
22. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev. 2002;23(6):787-823. doi:10.1210/er.2002-0003. (Pubitemid 35454589)
23. Bamberger C, Scharer A, Antsiferova M, Tychsen B, Pankow S, Muller M, et al. Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes. Am J Pathol. 2005;167(3):733-47. doi:10.1016/S0002-9440(10)62047-0. (Pubitemid 41216358)
24. Mayer K, Buchbinder A, Morty RE. Activin A: a mediator governing inflammation, immunity, and repair. Am J Respir Crit Care Med. 2012;185(4):350-2. doi:10.1164/rccm.201112-2210ED.
25. Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM, et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci USA. 2007;104(41):16239-44. doi:10.1073/pnas.0705971104. (Pubitemid 350099391)
26. Kawabata D, Tanaka M, Fujii T, Umehara H, Fujita Y, Yoshifuji H, et al. Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. Arthritis Rheum. 2004;50(2):660-8. doi:10.1002/art.20023. (Pubitemid 38198850)
27. Zhou J, Liao M, Hatta T, Tanaka M, Xuan X, Fujisaki K. Identification of a follistatin-related protein from the tick Haemaphysalis longicornis and its effect on tick oviposition. Gene. 2006;372:191-8. doi:10.1016/j.gene.2005.12. 020.
28. Tanaka M, Murakami K, Ozaki S, Imura Y, Tong XP, Watanabe T, et al. DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1 - analysis of their binding with TGF-beta superfamily proteins. FEBS J. 2010;277(20):4278-89. doi:10.1111/j.1742-4658.2010.07816.x.
29. Bork P. Shuffled domains in extracellular proteins. FEBS Lett. 1991;286(1-2):47-54.
30. Perkins SJ, Smith KF, Williams SC, Haris PI, Chapman D, Sim RB. The secondary structure of the von Willebrand factor type A domain in factor B of human complement by Fourier transform infrared spectroscopy. Its occurrence in collagen types VI, VII, XII and XIV, the integrins and other proteins by averaged structure predictions. J Mol Biol. 1994;238(1):104-19. doi:10.1006/jmbi.1994.1271.
31. Colombatti A, Bonaldo P, Doliana R. Type A modules: interacting domains found in several non-fibrillar collagens and in other extracellular matrix proteins. Matrix. 1993;13(4):297-306. (Pubitemid 23227044)
32. Tanaka M, Ozaki S, Kawabata D, Kishimura M, Osakada F, Okubo M, et al. Potential preventive effects of follistatin-related protein/TSC-36 on joint destruction and antagonistic modulation of its autoantibodies in rheumatoid arthritis. Int Immunol. 2003;15(1):71-7. (Pubitemid 36167785)
33. Le Luduec JB, Condamine T, Louvet C, Thebault P, Heslan JM, Heslan M, et al. An immunomodulatory role for follistatin-like 1 in heart allograft transplantation. Am J Transplant. 2008;8(11):2297-306. doi:10.1111/j.1600-6143. 2008.02398.x.
34. Thornton S, Sowders D, Aronow B, Witte DP, Brunner HI, Giannini EH, et al. DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin Immunol. 2002;105(2):155-68. (Pubitemid 35471663)
35. Clutter SD, Wilson DC, Marinov AD, Hirsch R. Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. J Immunol. 2009;182(1):234-9.
36. Ehara Y, Sakurai D, Tsuchiya N, Nakano K, Tanaka Y, Yamaguchi A, et al. Follistatin-related protein gene (FRP) is expressed in the synovial tissues of rheumatoid arthritis, but its polymorphisms are not associated with genetic susceptibility. Clin Exp Rheumatol. 2004;22(6):707-12. (Pubitemid 40045532)
37. Li D, Wang Y, Xu N, Wei Q, Wu M, Li X, et al. Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis. Arthritis Res Ther. 2011;13(1):R17. doi:10.1186/ar3241.
38. Gorelik M, Fall N, Altaye M, Barnes MG, Thompson SD, Grom AA, et al. Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2013;40(7):1191-9. doi:10.3899/jrheum.121131.
39. Widera C, Horn-Wichmann R, Kempf T, Bethmann K, Fiedler B, Sharma S, et al. Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay. Clin Chem. 2009;55(10):1794-800. doi:10.1373/clinchem.2009. 129411.
40. Gorelik M, Wilson DC, Cloonan YK, Shulman ST, Hirsch R. Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formation. J Pediatr. 2012;161(1):116-9. doi:10.1016/j.jpeds.2012.01.011.
41. Chaly Y, Fu Y, Marinov A, Hostager B, Yan W, Campfield B, et al. Follistatin-like protein 1 enhances NLRP3 inflammasome-mediated IL-1beta secretion from monocytes and macrophages. Eur J Immunol. 2014;. doi:10.1002/eji.201344063.
42. Hoffman HM. Therapy of autoinflammatory syndromes. J Allergy Clin Immunol. 2009;124(6):1129-38. doi:10.1016/j.jaci.2009.11.001 (quiz 39-40).
43. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29(3):301-5. doi:10.1038/ng756. (Pubitemid 33096455)
44. Gorelik M, Bushnell D, Goldbach-Mansky RT, Hoffman HM, Hirsch R. Elevated serum follistatin-like protein 1 suggests an interleukin-1 independent pathway for inflammation in patients with cryopyrin associated periodic syndromes. Arthritis Rheum. 2012;64(10):S1125-6.
45. Fan N, Sun H, Wang Y, Wang Y, Zhang L, Xia Z, et al. Follistatin-like 1: a potential mediator of inflammation in obesity. Mediators Inflamm. 2013;2013:752519. doi:10.1155/2013/752519.
46. Li KC, Zhang FX, Li CL, Wang F, Yu MY, Zhong YQ, et al. Follistatin-like 1 suppresses sensory afferent transmission by activating Na +, K + -ATPase. Neuron. 2011;69(5):974-87. doi:10.1016/j.neuron.2011.01.022.
47. Miyamae T, Marinov AD, Sowders D, Wilson DC, Devlin J, Boudreau R, et al. Follistatin-like protein-1 is a novel proinflammatory molecule. J Immunol. 2006;177(7):4758-62. (Pubitemid 44469810)
48. Bouffi C, Djouad F, Mathieu M, Noel D, Jorgensen C. Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit? Rheumatology. 2009;48(10):1185-9. doi:10.1093/rheumatology/kep162.
49. Ouchi N, Asaumi Y, Ohashi K, Higuchi A, Sono-Romanelli S, Oshima Y, et al. DIP2A functions as a FSTL1 receptor. J Biol Chem. 2010;285(10):7127-34. doi:10.1074/jbc.M109.069468.
50. Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183(2):787-91. doi:10.4049/jimmunol.0901363.
51. Shimano M, Ouchi N, Nakamura K, van Wijk B, Ohashi K, Asaumi Y, et al. Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload. Proc Natl Acad Sci USA. 2011;108(43):E899-906. doi:10.1073/pnas.1108559108.